California Bureau Chief for Leafly.com.
David Downs on KCRW
More from KCRW
Election deniers win primaries. Will voters lose faith in democracy?
PoliticsPanelists discuss surprising primary election wins, Kansas voters protecting abortion rights, and Speaker Nancy Pelosi’s controversial trip to Taiwan.
‘There’s no cavalry,’ says Mayor Garcetti on LA homelessness
HomelessnessMayoral candidates Karen Bass and Rick Caruso are making big promises on homelessness, but can they deliver? Outgoing Mayor Eric Garcetti says good luck.
With Manchin’s support (finally), can Democrats pass climate bill?
NationalPanelists discuss Senator Manchin reviving the climate agenda, Vice President Harris’ pronouns, and how divided the U.S. really is.
Trump might run in 2024. Will his support be affected by Jan. 6 revelations?
NationalPanelists discuss how President Biden is addressing fears of a recession, the latest January 6 hearing, and former President Trump’s potential 2024 run.
There’s 99% chance of COVID being aboard a plane, says doctor
TravelLA is experiencing another COVID surge. On an airplane of 50 passengers or in a restaurant of 20-30 diners, there’s a 90-99% chance that someone there has COVID, says Dr. Bob Wachter.
Illegal mining in Brazil: Danger for locals, resources for tech companies
EnvironmentPeople are illegally mining the Amazon rainforest for gold and tin ore. Some of those elements are going to Google and Apple. The mines are threatening Indigenous communities.
How Hollywood Bowl connects music lovers, from end of WWI to COVID
MusicThe Hollywood Bowl celebrates its centennial this July. KCRW looks at its origin story and legacy in LA. Listeners also share their favorite experiences there.
SCOTUS strikes down concealed-carry law. Is gun control in danger?
NationalWhat to expect of the Supreme Court’s decision to ease conceal-carry restrictions, Biden’s new gun safety law, and the Sandy Hook lawsuit?
Limitations of the Inflation Reduction Act of 2022
Health & WellnessThe new legislation offers some major successes, but with regard to drug pricing it is not close to what it could have been.